Related Experiment Video
Updated: Nov 6, 2025

05:51
An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
Published on: May 23, 2019
6.1K
Longitudinal predictive modeling of tau progression along the structural connectome
Fan Yang1, Samadrita Roy Chowdhury1, Heidi I L Jacobs2
1University of Massachusetts Lowell, Lowell, MA, United States.
Neuroimage
|May 6, 2021
Summary
This study introduces a new model to predict Alzheimer's disease (AD) tau progression using brain connectivity. The framework accurately forecasts tau spread, aiding in early diagnosis and personalized prognosis.
Area of Science:
- Neuroscience
- Medical Imaging
- Computational Biology
Background:
- Tau neurofibrillary tangles are key indicators of Alzheimer's disease (AD) progression and cognitive decline.
- Understanding tau transmission along neural pathways is crucial for predicting AD.
- Current methods lack personalized predictive capabilities for tau pathology.
Purpose of the Study:
- To develop an individualized predictive model for tau progression in Alzheimer's disease.
- To utilize a graph diffusion framework to model tau spread along the brain's structural connectome.
- To incorporate active tau generation and clearance into predictive modeling.
Main Methods:
- Developed an analytic graph diffusion framework with an inhomogeneous graph diffusion equation and source term.
- Utilized longitudinal tau positron emission tomography (PET) data (18F-Flortaucipir) and diffusion tensor imaging (DTI) from HABS and ADNI cohorts.
- Validated the model using two-timepoint PET scans for model fit and three-timepoint scans for predictive accuracy.
Main Results:
- The model demonstrated high consistency between predicted and observed regional tau measures.
- Analysis revealed differential tau spread patterns consistent with model predictions.
- Preliminary results show the model's potential for accurate in vivo tau progression forecasting.
Conclusions:
- The proposed graph diffusion model offers a promising personalized framework for predicting Alzheimer's disease tau progression.
- The model provides an in vivo macroscopic perspective on tau pathology spread.
- Further validation in larger cohorts is needed to confirm its prognostic value.

